Behavioural study
Effects of testosterone on Morris water maze (MWM) test in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
In the MWM test, the escape latency reflects the spatial learning progress. The escape latency was increased in AlCl3/d-gal during 2nd, 3rd, and 4th days of acquisition phase test by 258.18%, 314.57% and 197.35%, respectively, with respect to normal control group. Also, in overcrowded group, administration of AlCl3/d-gal to mice resulted in a marked elevation in escape latency during 2nd, 3rd, and 4th days of acquisition phase test by 325.94%, 711.83% and 318.19%, respectively, with respect to normal control group (Fig 2 a). As shown in Fig (2 a), treatment with testosterone-induced a prominent decrease in the escape latency during 2nd, 3rd, and 4th days of acquisition phase test by 30.18%, 28.96% and 40.58%, respectively, with respect to AlCl3/d-gal-intoxicated group. Similarly, treatment with testosterone reduced escape latency during 2nd, 3rd, and 4th days of acquisition phase test by 34.09%, 52.1% and 41.57%, respectively, with respect to AlCl3/d-gal-intoxicated group exposed to overcrowding (Fig 2 a).
Effects of testosterone on MWM test in probe test in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
As illustrated in Fig (2b), AlCl3/d-gal administration to mice exhibited a lower index of retrieval, which manifested as less time spent in target quadrant in MWM test by 50.24% with respect to normal control group. In the same context, administration of AlCl3/d-gal to overcrowded mice reduced the time spent in target quadrant in MWM test by 74.89% with respect to normal control group (Fig 2 b). While, treatment with testosterone-induced substantial increase in time spent in target quadrant in MWM test by 40.19% with respect to AlCl3/d-gal-intoxicated group (Fig 2b). Moreover, treatment with testosterone resulted in a remarkable elevation in time spent in target quadrant 30.76% with respect to AlCl3/d-gal-intoxicated group exposed to overcrowding (Fig 2 b).
Effects of testosterone on discrimination index (DI) and preference index (PI) using NOR test in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
The NOR test revealed that AlCl3/d-gal impaired non-spatial memory quantified by the DI and PI which were reduced by 276.92% and 33.92% respectively, with respect to normal control group (Fig 2 c, d). Fig (2 c, d) illustrated that administration of AlCl3/d-gal to overcrowded mice induced a significant decrease in DI and PI in NOR test by 576.92% and 75% respectively, with respect to normal control group. However, treatment with testosterone significantly increased the DI and PI in NOR test by 300% and 91.89% respectively, with respect to AlCl3/d-gal-intoxicated group (Fig 2 c, d). Likewise, treatment with testosterone significantly increased DI and PI in NOR test by 162.9% and 85.71% respectively, with respect to AlCl3/d-gal-intoxicated group exposed to overcrowding (Fig 2 c, d).
Effects of testosterone on total arm entries (TAE) spontaneous alternation percentage (SAP) using Y-maze test in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
As clarified in Fig (2 e, f), administration of AlCl3/d-gal to mice induced a significant decrease in TAE and SAP in Y-maze test by 43.11% and 24.33%, respectively with respect to normal control group. Furthermore, administration of AlCl3/d-gal to overcrowded mice induced a significant decrease in TAE and SAP in Y-maze test by 81.89% and 49.05%, respectively, with respect to normal control group (Fig 2 e, f). On the contrary, treatment with testosterone significantly increased TAE and SAP in Y-maze test by 64.41% and 22.63% with respect to AlCl3/d-gal-intoxicated group (Fig 2 e, f). In the same manner, treatment with testosterone significantly increased TAE and SAP in Y-maze test by 57.14% and 17.65%, respectively with respect to AlCl3/d-gal-intoxicated group exposed to overcrowding (Fig 2 e, f).
Effects of testosterone on the chosen biochemical parameters
Effects of testosterone on hippocampal and cortical amyloid-beta (Aβ), p-(ser404) Tau expression and brain-derived neurotrophic factor (BDNF) content in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
Fig (3 a, b and c) illustrated that induction of Alzheimer-like pathology by administration of AlCl3/d-gal to mice caused a marked increment in hippocampal and cortical Aβ content and p-(ser404) tau expression by 105.04%, 522.77% and decreased BDNF content by 56.74%, with respect to normal control group. Furthermore, administration of AlCl3/d-gal to overcrowded mice resulted in increased hippocampal and cortical Aβ content and p- (ser404) tau expression by 183.8% and 736.63% and decreased BDNF content by 67.82%, respectively with respect to normal control group. As shown in Fig (3 a, b and c), treatment with testosterone was associated with a significant diminution of hippocampal and cortical Aβ content and p-(ser404) tau expression by 38.67% and 51.83% and elevation of BDNF content by 101.8%, with respect to normal control group. In the same context, treatment of overcrowded mice with testosterone was associated with a significant diminution of hippocampal and cortical Aβ content and p- (ser404) tau expression by 40.44% and 54.32% and increased BDNF content by 79.88%, with respect to normal control group (Fig 3 a, b and c).
Effects of testosterone on hippocampal and cortical phosphorylated glycogen synthase kinase-3 beta (p-(ser9) GSK-3β), phosphatidylinositol-3-kinase (p-(Tyr458-199)-PI3K) protein expressions and protein kinase B (p-Akt) content in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
Fig (4 a, b and c) clarified that induction of Alzheimer-like symptoms by administration of AlCl3/d-gal to mice distinctly mitigated the hippocampal and cortical expression of p-(ser9) GSK-3β, p-(Tyr458-199)-PI3K and p-Akt content by 68.32%, 84.15% and 66.27%, respectively with respect to normal control group. Also, administration of AlCl3/d-gal to overcrowded mice resulted in a decreased hippocampal and cortical p-(ser9) GSK-3β, p-(Tyr458-199)-PI3K expression and p-AKT content by 81.11%, 89.1% and 63.64%, respectively with respect to normal control group (Fig 4 a, b and c). As illustrated in Fig (4 a, b and c), treatment with testosterone was associated with a significant elevation in hippocampal and cortical p-(ser9) GSK-3β, p-(Tyr458-199)-PI3K expression and p-Akt content by 125%, 350% and 111.06%, respectively with respect to AlCl3/d-gal control group. In addition, treatment of overcrowded mice with testosterone was associated with a significant increase of hippocampal and cortical p-(ser9) GSK-3β, p-(Tyr458-199)-PI3K expression and p-AKT content by 563.63%, 372.72% and 115.71%, respectively with respect to AlCl3/d-gal control group (Fig 4 a, b and c).
Effects of testosterone on hippocampal and cortical reduced glutathione (GSH), malondialdehyde (MDA) contents and nicotinamide adenine dinucleotide phosphate oxidase-1 (NOX-1) gene expression in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
As shown in Fig (5 a, b and c), administration of AlCl3/d-gal for 40 days to mice was accompanied by a significant decrease in hippocampal and cortical GSH content by 45.81% and a significant increase in hippocampal and cortical MDA content and NOX-1 gene expression by 240.34% and 711.88%, respectively with respect to normal control group. Also, in overcrowded group, administration of AlCl3/d-gal induced a significant decrease in hippocampal and cortical content of GSH by 53.87% and a significant increase in hippocampal and cortical MDA content and NOX-1 gene expression by 603.05% and 949.5%, respectively with respect to normal control group (Fig 5 a, b and c). Conversely, treatment with testosterone produced a further prominent elevation in hippocampal and cortical content of GSH by 63.7% and decreased hippocampal and cortical MDA content and NOX-1 gene expression by 35.79 % and 60.98%, respectively with respect to AlCl3/d-gal-intoxicated group (Fig 5 a, b and c). In the same manner, treatment of overcrowded mice with testosterone significantly increased hippocampal and cortical content of GSH content by 57.25% and decreased hippocampal and cortical MDA content and NOX-1 gene expression by 56.37% and 62.83%, respectively with respect to AlCl3/d-gal control group (Fig 5 a, b and c).
Effects of testosterone on hippocampal and cortical content of nuclear factor erythroid 2-related factor 2 (Nrf2), heme oxygenase 1 (HO-1) and cAMP response element binding protein (CREB) in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
Fig (6 a, b and c) illustrated that induction of Alzheimer-like pathology by administration of AlCl3/d-gal was associated with a significant diminution in hippocampal and cortical content of Nrf2, HO-1 and CREB by 58.77 %, 65.41% and 73.84%, respectively with respect to normal control group (Fig 6 a, b and c). Likewise, administration of AlCl3/d-gal to overcrowded mice resulted in decreased hippocampal and cortical content of Nrf2, HO-1 and CREB by 74.29%, 78.34% and 82.57%, respectively with respect to normal control group. Fig (6 a, b and c) clarified that treatment with testosterone was associated with an obvious elevation in hippocampal and cortical content of Nrf2, HO-1 and CREB by 87.69%, 136.28% and 74.81%, respectively with respect to AlCl3/d-gal control group. Similarly, treatment of overcrowded mice with testosterone was associated with significant elevation of hippocampal and cortical content of Nrf2, HO-1 and CREB by 81.46%, 125.29% and 51.25%, respectively with respect to AlCl3/d-gal control group (Fig 6 a, b and c).
Effects of testosterone on hippocampal and cortical content of tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β) and p38 mitogen-activated protein kinases (P38 MAPK) in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
As shown in Fig (7 a, b and c), induction of Alzheimer-like pathology by administration of AlCl3/d-gal to mice aggravated inflammatory states as reflected by prominent elevation in hippocampal and cortical content of TNF-α, IL-1β and p38 MAPK by 341.52%, 112.1% and 440.08% respectively with respect to normal control group. Moreover, administration of AlCl3/d-gal to overcrowded mice resulted in increased hippocampal and cortical content of TNF-α, IL-1β and p38 MAPK by 531.38%, 218.28% and 594.26%, respectively with respect to normal control group (Fig 7 a, b and c). In contrast, treatment with testosterone blunted the elevated hippocampal and cortical content of TNF-α, IL-1β and p38 MAPK by 55.66%, 42.21% and 58.27%, respectively with respect to AlCl3/d-gal control group (Fig 7 a, b and c). Similarly, treatment of overcrowded mice with testosterone showed a marked decrease in hippocampal and cortical content of TNF-α, IL-1β and p38 MAPK by 59.25%, 48.63% and 61.74%, respectively with respect to AlCl3/d-gal control group (Fig 7 a, b and c).
Effects of testosterone on hippocampal and cortical content of caspase-3 in mice subjected to AlCl3/d-gal-induced Alzheimer-like pathology
Fig (8) showed that induction of Alzheimer-like pathology by administration of AlCl3/d-gal to mice resulted in decreased hippocampal and cortical content of caspase-3 by 381.51% with respect to normal control group. Likewise, administration of AlCl3/d-gal to overcrowded mice resulted in decreased hippocampal and cortical content of caspase-3 by 596.57% with respect to normal control group (Fig 8). As clarified in Fig (8), treatment with testosterone was associated with significant elevation of hippocampal and cortical content of caspase-3 by 58.75% with respect to AlCl3/d-gal control group. Moreover, treatment of overcrowded mice with testosterone was associated with a significant elevation of hippocampal and cortical content of caspase-3 by 62.73% with respect to AlCl3/d-gal control group (Fig 8).
Correlation analysis
Correlation analysis between Aβ and behaviour results
Correlation analysis between Aβ and behaviour results in testosterone-treated mice
Solid negative correlation between Aβ and time spent in the target quadrant, SAP, TAE, DI and PI was detected as shown (Fig 9 a, b, c, d and e, r = - 0.83, -0.86, - 0.83, -0.82 and - 0.83; respectively, p < 0.0001).
Correlation analysis between Aβ and behaviours results in testosterone-treated mice
Solid positive correlation between Aβ and oxidative stress biomarkers (MDA and NOX-1) was detected as shown (Fig 10 a, b, r = 0.95 and r = 0.93; respectively, p < 0.0001), inflammatory biomarkers (TNF-α, IL-1β and P38 MAPK) was detected as shown (Fig 10 c, d and e, r = 0.97, r = 0.97 and r = 0.95 respectively, p < 0.0001), tau was detected as shown (Fig 10 f, r = 0.97, p < 0.0001) and apoptotic biomarker (caspase-3) (Fig 10 g, r = 0.94, p < 0.0001). However, there was a solid negative correlation between Aβ and GSH (Fig 10 h, r = - 0.94, p < 0.0001), Nrf2 and HO-1 (Fig 10 i, j, r = - 0.90 and r = - 0.92, respectively, p < 0.0001), BDNF and CREB was detected as shown (Fig 10 K and L, r = - 0.93 and r = - 0.87, p < 0.0001) and GSK-3β, PI3K and AKT (Fig 10 m, n and o, r = - 0.94, r = - 0.91 and r = - 0.80 respectively, p < 0.0001).
Histopathological examination of brain tissue
Histopathological examination of hippocampus and cortex in mice using hematoxylin and eosin (H & E) staining
Histopathological examination of brain sections of mice from normal control group showed normal structure of both cerebral cortex (Fig 11 a) and hippocampus (Fig 11 b). Histopathological examination of brain sections of mice that received AlCl3/d-gal followed by d-gal exhibited marked histopathological changes in both cerebral cortex and hippocampus. The cerebral cortex showed focal areas of malacia with gliosis (Fig 11 c). Hippocampus revealed dark degenerating neurons (Fig 11 d). While overcrowded mice showed variable histopathological changes in both cerebral cortex and hippocampus. The cerebral cortex showed cocal areas of malacia with gliosis accompanied by vasculitis (Fig 11 e). Hippocampus revealed dark degenerating neurons (Fig 11 f). Histopathological examination of brain sections of mice treated with a single dose of testosterone intoxicated by AlCl3/d-gal showed absence of histopathological changes in cerebral cortex (Fig 11 g) and the hippocampus exhibited normal CA1 region (Fig 11 h). Histopathological examination of brain of overcrowded mice treated with testosterone-intoxicated by AlCl3/d-gal showed numerous degenerated neurons in the cerebral cortex (Fig 11 i) and hippocampus revealed normal CA1 region (Fig 11 j). Regarding the pyknosis and degeneration score in both cerebral cortex and hippocampus (Fig 12), in comparison with AlCl3/d-gal group, testosterone-treated groups showed significant reduction in pyknosis and degeneration score.
Histopathological examination of hippocampus and cortex in mice using Nissl staining
Histopathological examination of Nissl-stained sections from normal control group revealed normal lightly stained neurons in cerebral cortex (Fig 13 a) and different regions of hippocampus (Fig 13 b). Histopathological examination of Nissl-stained sections of mice received AlCl3/d-gal exhibited numerous dark neurons in different regions in cerebral cortex (Fig 13 c), and CA3 and CA4 regions of hippocampus (Fig 13 d). Histopathological examination of Nissl-stained sections of overcrowded mice received AlCl3/d-gal revealed numerous dark neurons in the cerebral cortex (Fig 13 e). Dark neurons were markedly detected (Fig 13 f). Histopathological examination of Nissl-stained sections of mice treated with testosterone intoxicated by AlCl3/d-gal showed an apparently normal cerebral cortex (Fig 13 g) and few dark degenerating neurons in CA1 region of hippocampus was also observed (Fig 13 h). Histopathological examination of Nissl-stained of brain sections of overcrowded mice treated with testosterone intoxicated by AlCl3/d-gal showed improvement that revealed an increased number of dark neurons in the cerebral cortex (Fig 13 i) and apparently normal different hippocampus areas (Fig 13 j). Concerning the estimated neuronal survival rate in cerebral cortex and hippocampus (Fig 14) in comparison with AlCl3/d-gal-intoxicated group, testosterone-treated groups showed significant elevation in the estimated neuronal survival rate.
Glial fibrillary acidic protein (GFAP) examination
Examination of GFAP expression was conducted in different groups. Lower expression was determined in control group. Meanwhile, a significant increase in AlCl3/d-gal group compared to other experimental groups. Also, a significant increase in GFAP in AlCl3/d-gal overcrowded group compared to other experimental groups. Testosterone-treated group showed moderate GFAP expression in the cerebral cortex (Fig 15) and hippocampus (Fig 15). Overcrowded mice from testosterone-treated group showed moderate GFAP expression in the cerebral cortex (Fig 15) and hippocampus (Fig 15). Fig (16) illustrated Effect of testosterone on the histological score of the GFAP.